Minted: - / 5000

4213 Bradanicline
0397f39a306c4c8e3252eba0a56b9739d78cb5ecaa37d0a2de5a8c2b0f9d0415

Properties

Background

Green
Bottle

Pink
Cap

Yellow
Syringe

Yellow
Bubbles
No
Drops
No
Label
Cross

Chemistry

Formula
C22H23N3O2
Carbon
22
Polarity
Neutral

Bradanicline (INN, code name TC-5619) is a drug which was being developed by Targacept that acts as a partial agonist at the α7 subtype of the neural nicotinic acetylcholine receptors. It showed cognitive enhancing effects in animal studies, and was being developed through a collaboration between Targacept and AstraZeneca as a potential treatment for schizophrenia and attention deficit disorder. Phase I clinical trials were completed successfully, and it was in phase II trials..

From Wikipedia, the free encyclopedia. License: CC BY-SA.